Cyclooxygenase-2 expression during immortalization and breast cancer progression

Cancer Research
Xiangshan ZhaoVimla Band

Abstract

Identification of molecular aberrations in premalignant human mammary epithelial cells (hMEC), the precursors for breast cancers, is a central goal in breast cancer biology. Recent studies implicated expression of cyclooxygenase 2 (COX-2) as a marker to identify precursor cells for breast cancer. In this study, we analyzed COX-2 expression in preselection and postselection hMEC cells and observed similar COX-2 levels in both cells. Interestingly, immortalization of postselection cells using various methods leads to a dramatic decrease in COX-2 expression. Similar to immortal cells, the majority of breast cancer cell lines expressed low levels of COX-2 protein. Finally, analyses of COX-2 expression in a series of specimens from reduction mammoplasty, adenosis, ductal carcinoma in situ, and infiltrating ductal carcinoma showed down-regulation of COX-2 expression during tumor progression. Importantly, down-regulation of COX-2 using small interfering RNA in cells showed no effect on cell proliferation, anchorage-independent growth, migration, or invasion. These results show that (a) COX-2 overexpression does not seem to predict a breast cancer precursor cell and does not provide advantage for the cell to be transformed; (b) inhibit...Continue Reading

References

Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·V BandR Sager
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·M R Stampfer, J C Bartley
Jun 1, 1995·Seminars in Cancer Biology·V Band
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·D E WazerV Band
Jul 17, 1996·Journal of the National Cancer Institute·K M EganG A Colditz
Mar 1, 1996·Epidemiology·R E HarrisW B Farrar
Apr 1, 1998·Journal of the National Cancer Institute·D HwangE Levine
Apr 7, 1998·Molecular and Cellular Biology·S A FosterD A Galloway
Mar 30, 2001·The Journal of Biological Chemistry·C H LiuT Hla
Jun 9, 2001·Endocrine-related Cancer·L R HoweA J Dannenberg
Mar 20, 2002·The Journal of Biological Chemistry·Kotha SubbaramaiahAndrew J Dannenberg
Apr 18, 2002·Journal of the National Cancer Institute·Xueqin SongChing-Shih Chen
Aug 30, 2002·The International Journal of Biochemistry & Cell Biology·Paul Yaswen, Martha R Stampfer
Dec 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sung-Hee ChangTimothy Hla
Jan 22, 2004·British Journal of Cancer·G P BolandN J Bundred
Feb 20, 2004·Journal of Mammary Gland Biology and Neoplasia·M R Stampfer, P Yaswen
May 7, 2004·Current Opinion in Obstetrics & Gynecology·Danila Coradini, Maria Grazia Daidone
Apr 5, 2005·The Journal of Pharmacology and Experimental Therapeutics·Basil Rigas, Khosrow Kashfi
Jun 14, 2005·Biochemical Pharmacology·Khosrow Kashfi, Basil Rigas
Jul 1, 2005·Breast Cancer Research : BCR·Goberdhan DimriVimla Band
Jul 12, 2005·Nature Genetics·Min HuKornelia Polyak
Sep 1, 2005·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·P CejasM González-Barón
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sanjeewani T PalayoorC Norman Coleman

❮ Previous
Next ❯

Citations

Mar 30, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Nicola J HewittStefan Pfuhler
Jan 3, 2016·Drug Discovery Today·Miłosz RegulskiMarek Murias
Mar 17, 2010·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Javier de la TorreJordi Xercavins
Oct 18, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Cosmo RossiSaverio Alberti
Feb 11, 2015·PloS One·Chaitrali SahaSrinivas V Kaveri
Feb 20, 2016·American Journal of Physiology. Gastrointestinal and Liver Physiology·Roxane KhoogarMichael J Wargovich
Jan 15, 2020·Molecular and Cellular Biology·Eric C TomHamid Band
Jan 1, 2009·Breast Cancer : Basic and Clinical Research·Klaus H BaumannUwe Wagner
Aug 15, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Wanjun LiSongkai Long
Dec 10, 2018·ACS Biomaterials Science & Engineering·Ying WangBin Duan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Brandon L PierceCornelia M Ulrich
The Breast : Official Journal of the European Society of Mastology
M SucićJ Unusić
Journal of the National Cancer Institute
Eva-Maria BonebergGregor Fürstenberger
© 2021 Meta ULC. All rights reserved